NCCN Guidelines Insights: Multiple Myeloma, Version 1.2020.

Authors :: Kumar SK
Callander NS
Hillengass J
Liedtke M
Baljevic M
Campagnaro E
Castillo JJ
Chandler JC
Cornell RF
Costello C
Efebera Y
Faiman M
Garfall A
Godby K
Holmberg L
Htut M
Huff CA
Kang Y
Landgren O
Malek E
Martin T
Omel J
Raje N
Sborov D
Singhal S
Stockerl-Goldstein K
Tan C
Weber D
Johnson-Chilla A
Keller J
Kumar R
Source :: Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2019 Oct 01; Vol. 17 (10), pp. 1154-1165.
Publication Year :: 2019
Abstract: The NCCN Guidelines for Multiple Myeloma provide recommendations for diagnosis, workup, treatment, follow-up, and supportive care for patients with monoclonal gammopathy of renal significance, solitary plasmacytoma, smoldering myeloma, and multiple myeloma. These NCCN Guidelines Insights highlight some of the important updates and changes in the 1.2020 version of the NCCN Guidelines for Multiple Myeloma.

Full Text Access

Tools